1-20 of 28
Authors: Gilbert Youssef
Save search
Sort by
Journal Article

NIMG-66. DEFINING PROGRESSIVE DISEASE: LOCALIZING VOXEL-AT-RISK ON MAGNETIC RESONANCE IMAGING USING DEEP LEARNING Free

PDF
Nicolas Freeman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii210, https://doi.org/10.1093/neuonc/noae165.0830
Published: 11 November 2024
Journal Article

QOL-02. SOCIAL NETWORKS CAN BE QUANTITATIVELY MEASURED AND NETWORKS WITH GREATER STRUCTURAL DIVERSITY ARE ASSOCIATED WITH HIGHER HUMAN FLOURISHING Free

PDF
John Rhee and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii262, https://doi.org/10.1093/neuonc/noae165.1037
Published: 11 November 2024
Journal Article

RADT-40. EVALUATION OF SMALLER CLINICAL TARGET VOLUMES AND PATTERNS OF PROGRESSION IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA TO INFORM FUTURE DIRECTIONS IN RADIATION TREATMENT PLANNING Free

PDF
Jordan Hill and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii81, https://doi.org/10.1093/neuonc/noae165.0324
Published: 11 November 2024
Journal Article

DDDR-24. REAL WORLD EXPERIENCE USING THE IDH INHIBITOR IVOSIDENIB IN IDH MUTANT GLIOMA: TOLERABILITY AND OUTCOMES Free

PDF
Tyler Lanman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii130–viii131, https://doi.org/10.1093/neuonc/noae165.0509
Published: 11 November 2024
Journal Article

DISP-16. EXPLORING SEX-BASED DIFFERENCES IN RESPONSE TO IMMUNOTHERAPY IN GLIOBLASTOMA: A RETROSPECTIVE REVIEW Free

PDF
Catharina Westergaard and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii150, https://doi.org/10.1093/neuonc/noae165.0589
Published: 11 November 2024
Journal Article

PATH-27. MOLECULAR, IMAGING, AND SURVIVAL MANIFESTATIONS IN MOLECULAR GLIOBLASTOMAS: INSIGHTS FROM A MULTI-NATIONAL STUDY Free

PDF
Yae Won Park and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii184, https://doi.org/10.1093/neuonc/noae165.0726
Published: 11 November 2024
Journal Article

CTIM-28. NEOADJUVANT ANTI-PD1 IMMUNOTHERAPY FOR SURGICALLY ACCESSIBLE RECURRENT GLIOBLASTOMA: CLINICAL AND MOLECULAR OUTCOMES OF A STAGE 2 SINGLE-ARM EXPANSION COHORT Free

PDF
J Ricardo McFaline-Figueroa and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii92, https://doi.org/10.1093/neuonc/noae165.0361
Published: 11 November 2024
Journal Article

PATH-44. CLINICAL AND RADIOGRAPHIC PREDICTORS OF PROGNOSIS IN ASTROCYTOMA, IDH-MUTANT, WHO GRADE 4 Free

PDF
Aleksandra B Lasica and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Pages viii188–viii189, https://doi.org/10.1093/neuonc/noae165.0743
Published: 11 November 2024
Journal Article

Contemporary prognostic signatures and refined risk stratification of gliomas: An analysis of 4400 tumors Open Access

PDF
Hia S Ghosh and others
Neuro-Oncology, Volume 27, Issue 1, January 2025, Pages 195–208, https://doi.org/10.1093/neuonc/noae164
Published: 21 August 2024
Journal Article
EDITOR'S CHOICE

The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors? Open Access

PDF
Martin J van den Bent and others
Neuro-Oncology, Volume 26, Issue 10, October 2024, Pages 1805–1822, https://doi.org/10.1093/neuonc/noae107
Published: 24 June 2024
Journal Article

CTIM-39. A PHASE 1B STUDY OF PEMBROLIZUMAB, IBRUTINIB AND RITUXIMAB IN RECURRENT/REFRACTORY (RR) PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL) Free

PDF
Ugonma Chukwueke and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v71–v72, https://doi.org/10.1093/neuonc/noad179.0279
Published: 10 November 2023
Journal Article

CTIM-37. A PILOT STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL) FOR THE TREATMENT OF RELAPSED/REFRACTORY PRIMARY AND SECONDARY CENTRAL NERVOUS SYSTEM LYMPHOMA (PCNSL AND SCNSL) Free

PDF
Lakshmi Nayak and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v71, https://doi.org/10.1093/neuonc/noad179.0277
Published: 10 November 2023
Journal Article

INNV-16. COMPARISON OF SURVIVAL OUTCOMES OF RECURRENT GLIOBLASTOMA PATIENTS: A COMPARISON BETWEEN PATIENTS ENROLLED INTO CLINICAL TRIALS AND PATIENTS THAT DID NOT ENROLL INTO TRIALS AT FIRST PROGRESSION Free

PDF
Geethanjali Balasubramanian and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v159–v160, https://doi.org/10.1093/neuonc/noad179.0605
Published: 10 November 2023
Journal Article

NIMG-52. CORRELATION OF BIDIMENSIONAL AND VOLUMETRIC TUMOR SIZING IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA Free

PDF
John Kim and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v197–v198, https://doi.org/10.1093/neuonc/noad179.0748
Published: 10 November 2023
Journal Article

Objective response rate targets for recurrent glioblastoma clinical trials based on the historic association between objective response rate and median overall survival Open Access

PDF
Benjamin M Ellingson and others
Neuro-Oncology, Volume 25, Issue 6, June 2023, Pages 1017–1028, https://doi.org/10.1093/neuonc/noad002
Published: 07 January 2023
Journal Article

Phase I study of a novel glioblastoma radiation therapy schedule exploiting cell-state plasticity Open Access

PDF
Jamie A Dean and others
Neuro-Oncology, Volume 25, Issue 6, June 2023, Pages 1100–1112, https://doi.org/10.1093/neuonc/noac253
Published: 19 November 2022
Journal Article

NIMG-42. DURABLE OVERALL RESPONSE RATE (ORR) TARGETS FOR RECURRENT GLIOBLASTOMA (RGBM) CLINICAL TRIALS BASED ON THE HISTORIC ASSOCIATION BETWEEN ORR AND MEDIAN OVERALL SURVIVAL (MOS) Free

PDF
Benjamin Ellingson and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Pages vii172–vii173, https://doi.org/10.1093/neuonc/noac209.660
Published: 14 November 2022
Journal Article

BIOM-37. EVALUATION OF TEMPORALIS MUSCLE THICKNESS WITH TOXICITY AND SURVIVAL IN GLIOBLASTOMA PATIENTS RECEIVING CHEMORADIATION Free

PDF
Anurag Saraf and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii12, https://doi.org/10.1093/neuonc/noac209.047
Published: 14 November 2022
Journal Article

NIMG-59. EVALUATION OF THE RESPONSE ASSESSMENT CRITERIA IN NEWLY DIAGNOSED AND RECURRENT GLIOBLASTOMA Free

PDF
Gilbert Youssef and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii177, https://doi.org/10.1093/neuonc/noac209.677
Published: 14 November 2022
Journal Article

PATH-15. THE PROGNOSTIC IMPLICATION OF MGMT PROMOTER METHYLATION IN IDH-MUTANT GLIOMAS Free

PDF
Gilbert Youssef and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii153, https://doi.org/10.1093/neuonc/noac209.588
Published: 14 November 2022